Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hongzhen zhong
The Role of Hypoxia-Inducible Factor Stabilizers in the Treatment of Anemia in Patients With Chronic Kidney Disease
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
American Journal of Kidney Diseases
Nephrology
Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents
Current Medical Research and Opinion
Medicine
Renal Anaemia: The Role of Haemoglobin Control in Patients With Chronic Kidney Disease
Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
Multidisciplinary
Hypoxia-Inducible Factor 1 (HIF-1) as a Biomarker of Acute Kidney Injury in Patients With Acute Decompensation of Chronic Heart Failure
Kardiologiya
Cardiovascular Medicine
Cardiology
Involvement of Hypoxia-Inducible Transcription Factors in Polycystic Kidney Disease
American Journal of Pathology
Forensic Medicine
Pathology
MicroRNA-186 Is Associated With Hypoxia-Inducible Factor-1α Expression in Chronic Obstructive Pulmonary Disease
Molecular genetics & genomic medicine
Genetics
Molecular Biology
The Use of Metformin in Patients With Chronic Kidney Disease
Annales Academiae Medicae Silesiensis
Pharmacoeconomic Analysis of Сosmofer (Iron III - Hydroxide Dextran) in the Treatment of Iron Deficiency Anemia for Chronic Kidney Disease Patients
Pharmacoeconomics: theory and practice
Increased Expression of Hypoxia-Inducible Factor 1α in Coeliac Disease
Pediatric Research
Child Health
Pediatrics
Perinatology